Gossamer Bio, Inc.
GOSS
$0.16
-$0.02-11.23%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 16.90M | -46.66M | -47.24M | -48.22M | -38.27M |
| Total Depreciation and Amortization | 252.00K | 232.00K | 227.00K | 220.00K | 213.00K |
| Total Amortization of Deferred Charges | 4.96M | 255.00K | 251.00K | 248.00K | 245.00K |
| Total Other Non-Cash Items | -47.49M | 5.64M | 1.81M | 8.56M | 642.00K |
| Change in Net Operating Assets | -14.04M | 1.81M | -3.36M | 3.03M | -9.89M |
| Cash from Operations | -39.42M | -38.72M | -48.31M | -36.17M | -47.06M |
| Capital Expenditure | -- | -- | 0.00 | 0.00 | -53.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 42.70M | 41.61M | 73.16M | 17.01M | 44.18M |
| Cash from Investing | 42.70M | 41.61M | 73.16M | 17.01M | 44.13M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 512.00K | 3.96M | 1.87M | 94.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.14M | -- | -- | -- | -- |
| Cash from Financing | -3.14M | 512.00K | 3.96M | 1.87M | 94.00K |
| Foreign Exchange rate Adjustments | -12.00K | -101.00K | 2.00K | -95.00K | 129.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 120.00K | 3.30M | 28.80M | -17.38M | -2.71M |